Welcome to our dedicated page for Nephros news (Ticker: NEPH), a resource for investors and traders seeking the latest updates and insights on Nephros stock.
Nephros, Inc. (Nasdaq: NEPH) is a water technology company focused on filtration products, services, and water-quality education for medical, healthcare, commercial, and industrial markets. The NEPH news feed highlights how the company’s filtration solutions and educational initiatives are applied in practice, as well as how its financial performance evolves over time.
News about Nephros often includes quarterly and year-to-date financial results, where the company reports net revenue, net income or loss, gross margin, and adjusted EBITDA. These updates frequently discuss programmatic revenue tied to recurring filter use, emergency response sales related to compromised water events, and trends in service revenue. Investors can use these releases to understand how Nephros’ programmatic business and active customer sites are developing across infection control, dialysis water, and commercial segments.
The NEPH news stream also covers product launches and technology developments. Examples include new filtration products designed to support compliance with water quality standards and to extend Nephros’ technology into additional medical, commercial, and industrial applications. These announcements explain how new offerings fit within the company’s portfolio and which types of facilities or industries they are intended to serve.
Another recurring theme in Nephros news is water safety education. The company reports on webinars, speaking engagements, and the activities of the Nephros Water Institute, which provides regulatory and risk-based educational programming for professionals responsible for water systems. Together, these financial, product, and educational updates give a rounded view of Nephros’ operations and strategic focus. Users interested in NEPH can review this page regularly for the latest company-issued press releases and related disclosures.
Nephros, Inc. (Nasdaq: NEPH), a leader in advanced filtration technology, has responded rapidly to the recent hurricanes Helene and Milton that devastated parts of the southeastern United States. The company provided important water filtration solutions to multiple healthcare and nursing care facilities affected by the storms, ensuring a safe water supply for patients and staff during recovery efforts.
Nephros has shipped a significant number of filters, responding after hours and delivering next day to both federal and local disaster response partners. Their solutions have been deployed across multiple states and facility types, including:
- Florida hospitals where Nephros in-line filters were previously installed
- North Carolina nursing and care facilities where point-of-use filters provided immediate protection against bacteria
The company's ability to act quickly in disaster response situations underscores its commitment to clean water access, offering an effective alternative to typical emergency water sources.
Nephros (NEPH) reported Q2 2024 financial results with net revenue of $3.3 million, an 8% decrease from Q2 2023. However, programmatic revenue increased by 8% year-over-year, driven by over 300 new accounts added in the past 12 months. The company reported a net loss of $0.3 million, an improvement from $0.4 million in Q2 2023. Adjusted EBITDA was ($133,000), compared to ($183,000) in the prior year.
CEO Robert Banks highlighted growth in the core programmatic business but noted a decline in emergency response sales. The company is developing new business models to address challenges in filter changeout schedules. As of June 30, 2024, Nephros had cash and cash equivalents of $3.1 million.
Nephros Inc (Nasdaq: NEPH), a leading water technology company, has announced its schedule for the second quarter 2024 financial results conference call. The company will file its Q2 financial results on Thursday, August 8, 2024 after market close and host a conference call at 4:30pm ET the same day. Participants can join the call using the following dial-in numbers:
- Domestic access: 1 (844) 808-7106
- International access: 1 (412) 317-5285
An audio archive will be available on the Nephros Investor Relations page shortly after the call. A replay will also be accessible until August 15, 2024, using specific replay access codes for domestic and international callers.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Nephros (NEPH)?
What is the market cap of Nephros (NEPH)?
